Mar 2021

ANTG APPOINTS JUSTIN SINCLAIR AS CHIEF SCIENTIFIC OFFICER

Australian Natural Therapeutics Group (ANTG) has appointed adjunct research fellow at Western Sydney University (WSU) Justin Sinclair as chief scientific officer.

Sinclair will work on projects including pre-clinical research with the University of Newcastle around the potential of ANTG’s Eve Cannabis to kill or inhibit cancer cells, and a partnership with WSU’s NICM Health Research Institute on using cannabis-based medicine to improve cognitive function.

More here

Australian Natural Therapeutics Group (ANTG) will ship locally cultivated and […]

READ MORE >

Two medicinal marijuana companies have fast-tracked plans to build a […]

READ MORE >

Australia is poised to become a leader in medicinal cannabis […]

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >